LORETELLI, CRISTIAN
 Distribuzione geografica
Continente #
EU - Europa 9.039
AS - Asia 7.305
NA - Nord America 6.679
SA - Sud America 1.102
AF - Africa 333
OC - Oceania 110
Continente sconosciuto - Info sul continente non disponibili 4
Totale 24.572
Nazione #
US - Stati Uniti d'America 6.069
IT - Italia 3.288
CN - Cina 2.343
GB - Regno Unito 1.600
SG - Singapore 1.326
DE - Germania 1.065
BR - Brasile 707
HK - Hong Kong 570
IN - India 528
FR - Francia 457
SE - Svezia 385
RU - Federazione Russa 356
VN - Vietnam 340
BD - Bangladesh 339
JP - Giappone 335
ID - Indonesia 318
ES - Italia 313
MX - Messico 269
NL - Olanda 259
CA - Canada 256
TR - Turchia 244
FI - Finlandia 213
PL - Polonia 159
TW - Taiwan 154
PT - Portogallo 143
IE - Irlanda 135
SA - Arabia Saudita 135
KR - Corea 115
DK - Danimarca 113
EG - Egitto 106
BE - Belgio 103
CO - Colombia 103
AU - Australia 100
IR - Iran 99
EC - Ecuador 89
TH - Thailandia 82
CH - Svizzera 81
AT - Austria 77
PH - Filippine 69
CI - Costa d'Avorio 62
PK - Pakistan 60
AR - Argentina 59
CL - Cile 55
GR - Grecia 50
PE - Perù 45
IQ - Iraq 37
ZA - Sudafrica 35
RO - Romania 31
VE - Venezuela 31
AE - Emirati Arabi Uniti 30
DZ - Algeria 30
JO - Giordania 26
RS - Serbia 26
UA - Ucraina 25
HR - Croazia 23
MA - Marocco 20
SK - Slovacchia (Repubblica Slovacca) 20
MY - Malesia 19
LB - Libano 18
NO - Norvegia 18
CZ - Repubblica Ceca 17
HU - Ungheria 17
CR - Costa Rica 15
GT - Guatemala 15
LY - Libia 15
KE - Kenya 14
NP - Nepal 14
UZ - Uzbekistan 14
SV - El Salvador 13
IL - Israele 12
NG - Nigeria 12
TN - Tunisia 11
BH - Bahrain 10
BY - Bielorussia 10
NZ - Nuova Zelanda 10
BA - Bosnia-Erzegovina 9
PS - Palestinian Territory 9
EE - Estonia 8
LT - Lituania 8
PR - Porto Rico 8
PY - Paraguay 8
SC - Seychelles 7
SY - Repubblica araba siriana 7
JM - Giamaica 6
LK - Sri Lanka 6
ME - Montenegro 6
OM - Oman 6
SI - Slovenia 6
SN - Senegal 6
CY - Cipro 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
HN - Honduras 5
KW - Kuwait 5
KZ - Kazakistan 5
QA - Qatar 5
AL - Albania 4
BO - Bolivia 4
GE - Georgia 4
MO - Macao, regione amministrativa speciale della Cina 4
Totale 24.513
Città #
Southend 1.129
Singapore 734
Milan 708
Ashburn 663
Dallas 489
Hong Kong 425
Hanover 292
Beijing 291
Chandler 280
San Jose 263
Fairfield 256
Los Angeles 190
Council Bluffs 170
Rome 157
Helsinki 156
New York 149
Wilmington 146
Munich 145
Shanghai 143
Santa Clara 140
Dublin 133
Istanbul 132
Houston 123
Jakarta 121
Seattle 120
Guangzhou 116
Tokyo 116
Frankfurt am Main 115
Princeton 114
Dearborn 105
Cambridge 101
Nanjing 99
Boardman 95
Woodbridge 95
Hefei 94
Ann Arbor 93
Hanoi 88
Ho Chi Minh City 88
Bengaluru 86
Riyadh 82
London 80
Moscow 77
São Paulo 75
Toronto 75
Buffalo 72
Lauterbourg 71
Redwood City 68
Paris 66
Bodio Lomnago 65
Abidjan 62
Turin 57
Phoenix 55
Vienna 55
Barcelona 51
Chicago 51
Des Moines 51
The Dalles 50
Madrid 49
Mumbai 49
Shenzhen 49
Hangzhou 48
Hyderabad 48
Taipei 45
Warsaw 45
Amsterdam 44
Bogotá 44
Changsha 39
Stockholm 39
Bangkok 38
Boston 38
Central 38
Chennai 38
Santiago 38
Seoul 38
Shenyang 38
Wuhan 38
Madison 37
Tehran 37
Atlanta 36
Berlin 34
Cairo 34
Rio de Janeiro 34
Brussels 33
Jinan 33
Nuremberg 33
Tianjin 32
Lisbon 31
Naples 30
Quito 30
Washington 30
Lima 29
Pune 29
San Diego 29
Sydney 29
Bologna 28
Columbus 28
Florence 27
Genoa 27
Mexico City 27
Montreal 27
Totale 11.670
Nome #
Anti-diabetic drugs and weight loss in patients with type 2 diabetes 4.643
Cell therapy for type 1 diabetes 2.786
Anti-inflammatory effects of diet and caloric restriction in metabolic syndrome 873
Long-Term Activity and Safety of a Low-Dose Hydrocortisone Tear Substitute in Patients with Dry Eye Disease 868
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 682
Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets 666
The IGFBP3/TMEM219 pathway regulates beta cell homeostasis 659
miR-21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy 534
Next-gen therapeutics to spare and expand beta-cell mass 482
Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes 455
Prostaglandin E2 stimulates the expansion of regulatory hematopoietic stem and progenitor cells in type 1 diabetes 366
Effetto protettivo della restrizione calorica nella sindrome metabolica: miglioramento del profilo lipidomico e dell’attività anti-infiammatoria citochinica ed enzimatica (CETP) 315
Idebenone and T2D : A new insulin-sensitizing drug for personalized therapy 314
Placental proteome abnormalities in women with gestational diabetes and large-for-gestational-age newborns 304
MSH2 missense mutations and HNPCC syndrome: Pathogenicity assessment in a human expression system 300
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection 278
The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists 274
The IL-8-CXCR1/2 axis contributes to diabetic kidney disease 274
PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response 270
Rice flour fermented with Lactobacillus paracasei CBA L74 in the treatment of atopic dermatitis in infants: A randomized, double- blind, placebo- controlled trial 260
Embryonic stem cell extracts improve wound healing in diabetic mice 254
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab 241
Repeatability and reproducibility of the wzi high resolution melting-based clustering analysis for Klebsiella pneumoniae typing 239
Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule 237
The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age 235
Embryonic Cell Extracts Ameliorate Wound Healing in Diabetic Mice 228
Intragenic antagonistic roles of protein and circRNA in tumorigenesis 221
Hematopoietic Stem Cells in Type 1 Diabetes 220
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients 217
Efficacy of sorafenib in BRAF-mutated nonsmall- cell lung cancer (NSCLC) and no response in synchronous BRAF wild typehepatocellular carcinoma : A case report 217
Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease 215
From pseudo-ceRNAs to circ-ceRNAs: a tale of cross-talk and competition 212
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 209
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 208
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE : Implications for clinical management 207
Abnormalities of the oculomotor function in type 1 diabetes and diabetic neuropathy 198
Cancer Stem Cell Gene Profile as Predictor of Relapse in High Risk Stage II and Stage III, Radically Resected Colon Cancer Patients 188
Inflammation and vascular dysfunction: The negative synergistic combination of diabetes and COVID-19 187
Dapagliflozin acutely improvMED/es kidney function in type 2 diabetes mellitus. The PRECARE study 185
TMEM219 regulates the transcription factor expression and proliferation of beta cells 184
A new glucose monitoring system for the intermittent monitoring of interstitial glucose values in patients with diabetes mellitus 180
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 180
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: Implications for clinical management 179
Sitagliptin favorably modulates immune-relevant pathways in human beta cells 178
Vaccinome landscape in nearly 620 000 patients with diabetes 177
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients 173
Anidulafungin in combination with amphotericin B against Aspergillus fumigatus 171
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab 162
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib : The ALICE-1 study 162
Prevalence and significance of mesentery thickening and lymph nodes enlargement in Crohn's disease 160
Targeting of the IGFBP3/TMEM219 pathway restores intestinal stem cells capability of healing mucosa in gastrointestinal autoimmune disorders 157
Immunoevasion rather than intrinsic oncogenicity may confer MSCs from non-obese diabetic mice the ability to generate neural tumors 155
Lipidome profile of Cystic Fibrosis Related Diabetes, Type 1 and Type 2 Diabetes Mellitus: potential links to inflammation and glucose and lipid metabolism 155
eATP and autoimmune diabetes 154
Long-term cytokine profile in multisystem inflammatory disease among children 154
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab 154
MSH2 splice site mutation and endometrial cancer 149
Daytime hypoglycemic episodes during the use of an advanced hybrid closed loop system 148
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients 147
Novel Soluble Mediators of Innate Immune System Activation in Solid Allograft Rejection 144
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 143
TMEM219 signaling promotes intestinal stem cell death and exacerbates colitis 140
'Secrets and lies' : the difficulties of communicating within families with inherited cancer syndromes 140
Epidermal growth factor receptor gene promoter methylation in primary colorectal tumors and corresponding metastatic sites : a new perspective for an "old" therapeutic target 132
HER family receptor expression and prognosis in pancreatic cancer 129
Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression 117
Effectiveness of the CRCAPRO program in identifying patients suspected for HNPCC 113
A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy 108
BRCA1 expression in triple negative sporadic breast cancers 108
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients 106
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 105
Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: Correlation with clinical, genetic and functional features 104
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients 104
An intronic mutation in MLH1 associated with familial colon and breast cancer 101
GLP-1 receptor agonists and coronary plaques regression in diabetic patients after acute coronary syndromes 96
Sub-cellular localization analysis of MSH6 missense mutations does not reveal an overt MSH6 nuclear transport impairment 96
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 86
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab 83
Totale 25.155
Categoria #
all - tutte 58.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.258


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021176 0 0 0 0 0 0 0 0 0 0 0 176
2021/20222.088 132 131 119 200 219 149 156 185 197 247 138 215
2022/20233.134 163 175 232 243 264 372 258 279 379 208 310 251
2023/20244.113 281 312 342 414 598 374 252 310 213 290 385 342
2024/20255.340 308 380 333 433 414 338 510 574 433 519 518 580
2025/20267.271 668 553 951 631 609 470 907 363 581 452 727 359
Totale 25.155